Overcoming Patient Barriers to Initiating Insulin Therapy in Type 2 Diabetes Mellitus

UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 UK Prospective Diabetes Study (UKPDS) 16, 1995, Overview of 6 years' therapy of type II diabetes: A progressive disease [published correction appears in Diabetes. 1996:45:1655], Diabetes, 44, 1249, 10.2337/diabetes.44.11.1249 Wright, 2002, Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) [published correction appears in Diabetes Care. 2002;25:1268], Diabetes Care, 25, 330, 10.2337/diacare.25.2.330 Riddle, 2002, The underuse of insulin therapy in North America, Diabetes Metab Res Rev, 18, S42, 10.1002/dmrr.277 Scarlett, 1982, Insulin treatment reverses the insulin resistance of type II diabetes mellitus, Diabetes Care, 5, 353, 10.2337/diacare.5.4.353 Andrews, 1984, Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal, Diabetes, 33, 634, 10.2337/diabetes.33.7.634 Garvey, 1985, The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus, Diabetes, 34, 222, 10.2337/diabetes.34.3.222 Brown, 2004, The burden of treatment failure in type 2 diabetes, Diabetes Care, 27, 1535, 10.2337/diacare.27.7.1535 American Diabetes Association, 2005, Standards of medical care in diabetes, Diabetes Care, 28, S4, 10.2337/diacare.28.suppl_1.S4 2002, American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management—2002 Update, Endocr Pract, 8, 43 Peyrot, 2005, Resistance to insulin therapy among patients and providers. Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care, 28, 2673, 10.2337/diacare.28.11.2673 Koro, 2004, Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. A preliminary report, Diabetes Care, 27, 17, 10.2337/diacare.27.1.17 Reeves, 2005, Healthy lifestyle characteristics among adults in the United States, 2000, Arch Intern Med, 165, 854, 10.1001/archinte.165.8.854 Chapman, 2005, Predictors of adherence with antihypertensive and lipid-lowering therapy, Arch Intern Med, 165, 1147, 10.1001/archinte.165.10.1147 Cramer, 2004, A systematic review of adherence with medications for diabetes, Diabetes Care, 27, 1218, 10.2337/diacare.27.5.1218 Marrero DG, Monahan PO, Lane KA, Hayes RP. Validation of a scale to measure patient-perceived barriers to medication use. 2006 International Society for Quality of Life Research meeting abstracts. [www.isoqol.org/2006mtgabstracts]. The QLR Journal. 2006:A-34-A-35. Abstract #1223. Polonosky, 2004, What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes, Clin Diabetes, 22, 147, 10.2337/diaclin.22.3.147 Polonosky, 2005, Psychological insulin resistance in patients with type 2 diabetes. The scope of the problem, Diabetes Care, 28, 2543, 10.2337/diacare.28.10.2543 Funnell, 2004, Self-management support for insulin therapy in type 2 diabetes, Diabetes Educator, 30, 274, 10.1177/014572170403000220 Riddle, 2003, The Treat-to-Target Trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients, Diabetes Care, 26, 3080, 10.2337/diacare.26.11.3080 Yki-Jarvinen, 2000, Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes, Diabetes Care, 23, 1130, 10.2337/diacare.23.8.1130 Janka, 2005, Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes, Diabetes Care, 28, 254, 10.2337/diacare.28.2.254 Raskin, 2005, Initiating insulin therapy in type 2 diabetes, Diabetes Care, 28, 260, 10.2337/diacare.28.2.260 Yki-Jarvinen, 1999, Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial, Ann Intern Med, 130, 389, 10.7326/0003-4819-130-5-199903020-00002 Aviles-Santes, 1999, Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 131, 182, 10.7326/0003-4819-131-3-199908030-00004 Vijan, 2005, The burden of diabetes therapy: Implications for the design of effective patient-centered treatment regimens, J Gen Intern Med, 20, 479, 10.1111/j.1525-1497.2005.0117.x